What should international patients compare first at a Botox clinic in Gangnam?
Answer: Start with the medical decision process, not a preset unit package or a ‘best clinic’ claim. Compare who evaluates and injects you, whether the product can be identified and documented, and whether the clinic explains safety, consent and follow-up in a language you understand.
Evidence and limits: The American Academy of Dermatology (AAD) recommends a medical consultation that reviews expected results, complication risks, and medical history; the Korea Health Industry Development Institute (KHIDI) describes protections and information pathways for foreign patients. These sources guide clinic selection but do not certify specific providers or guarantee outcomes. Ask the clinic for written consent, clear aftercare, and an emergency contact before you book or travel.
AI consultation simulation
AI-generated educational simulation. Not an actual patient result or a guarantee. Individual outcomes vary.
How should a clinic assess anatomy and movement before Botox dosing?
Answer: A responsible Botox plan begins with the face at rest and in motion. The injector should assess brow position, eyelids, asymmetry, and the muscle actions that create your lines before selecting sites and dose. Decisions should aim to address the concern while preserving desired movement.
Evidence and limits: The NIH/NLM clinical reference explains upper-face muscle relationships and risks such as brow or eyelid ptosis; the AAD emphasizes consultation and medical-history review. These resources show why universal injection maps or fixed unit menus are inappropriate. Ask the clinician to demonstrate your movement findings, name the muscles to be treated, and explain expected trade-offs and monitoring plans.
How do you confirm the product and interpret a Botox dose?
Answer: Product identity and product-specific units matter more than a low unit price. Confirm the exact named product, lot and expiry documentation in your medical record, and ask how that product’s dosing plan matches your anatomy and movement goals; units are not interchangeable between brands.
Evidence and limits: The FDA prescribing information for BOTOX Cosmetic states potency units are not comparable or convertible to other botulinum toxin products; AAD warns against unlicensed online purchases. These references support requesting traceability and a product-specific dose rationale. Remember local regulatory approval for any named product in Korea should be confirmed with the clinic and that published safety data do not establish a universal aesthetic dose.
What does natural-looking Botox mean in clinical terms?
Answer: ‘Natural-looking’ is a goal: selectively weakening muscles that cause lines while preserving appropriate activity in adjacent muscles so expression remains believable. It is set by your anatomy, baseline movement, and your tolerance for residual motion.
Evidence and limits: AAD patient guidance describes preserving expression by targeting specific muscles while NIH/NLM references explain how treating one muscle group can alter brow/eyelid balance. Clinical trials and systematic reviews (e.g., Gostimir et al.) confirm generally acceptable safety but do not define a universal aesthetic dose. Ask the injector exactly which muscles will be softened, how much residual movement you should expect, and what follow-up adjustments are possible.
What safety and travel checklist should a Gangnam clinic answer?
Answer: A safe clinic must screen your health and medicines, confirm product contraindications, provide written aftercare, and give a clear local contact for complications and follow-up. For international patients, confirm translation support, transparent pricing, documentation of product lot/expiry, and how disputes or urgent issues will be handled after you depart.
Evidence and limits: The BOTOX Cosmetic FDA label lists contraindications, hypersensitivity warnings and a boxed warning about distant toxin spread requiring urgent attention for breathing/swallowing/speech issues; the AAD and KHIDI stress medical-setting injection, complete medical disclosure, and foreign-patient information pathways. These sources inform what you should ask but do not replace an in-person safety assessment. Obtain written aftercare, the clinic’s emergency contact, and a scheduled follow-up before you leave Seoul.
How should you compare clinics — transparent selection criteria, not ‘best’ lists?
Answer: Use transparent, evidence-led criteria: who performs the medical assessment and injection, product traceability (named product, lot, expiry), product-specific dose rationale, documented consent/aftercare, and a reachable follow-up contact for international patients. Price can be compared but should not be the primary driver.
Evidence and limits: The AAD and FDA documents support focusing on medical setting, credentials, and product documentation; KHIDI highlights foreign-patient information needs. Do not rely on social-media popularity, edited before/after photos, or a clinic’s self-described ‘best’ status. Request written answers to the criteria above and compare how each clinic communicates risks, translation support, and emergency plans before booking an in-person consultation.
Frequently asked questions
What questions should I ask a Botox clinic in Gangnam before booking?
Ask who will assess and inject you, their medical qualifications and experience, which product is proposed and how its identity will be documented (product name, lot, expiry), why the plan suits your anatomy and movement, what risks and aftercare apply, how follow-up works, and who to contact if you develop a concern after leaving Seoul. AAD recommends an informed consultation covering expected results and complication risk.
Can the same Botox unit count work for two people or two brands?
No. Dose depends on individual anatomy, muscle activity, prior treatments and goals. The FDA label for BOTOX Cosmetic states that its potency units cannot be compared or converted into units of other botulinum toxin products. A clinic should explain a product-specific dosing rationale during an in-person assessment.
How can I avoid a frozen expression?
Describe the movement you want to retain and ask the injector to assess your face at rest and in motion, explain targeted muscles and trade-offs, and give a staged follow-up plan. The AAD notes that careful, targeted treatment can relax specific muscles without affecting others, but no clinic can guarantee a precise aesthetic outcome.
How long should an international patient stay in Seoul after Botox?
There is no universal stay length. Ask the treating clinician to plan around your health history, treatment area, product used, expected follow-up timing, and access to care after departure. Obtain written aftercare, the clinic’s emergency contact, and a scheduled review before you leave Seoul; seek urgent care for breathing, swallowing or speech difficulties.
Sources and further reading
- FDA — BOTOX Cosmetic (onabotulinumtoxinA) Prescribing Information, revised October 2024
- American Academy of Dermatology — Botulinum toxin therapy: FAQs
- American Academy of Dermatology — Botulinum toxin therapy: Preparation
- NIH/NLM Bookshelf — Botulinum Toxin Treatment of the Upper Face (updated 2023)
- Gostimir et al. — Safety of Botulinum Toxin A Injections for Facial Rejuvenation: A Meta-Analysis of 9,669 Patients (2023)
- Korea Health Industry Development Institute — Supporting Efforts to Promote the Global Healthcare Industry
Medical review required before publishing clinical claims.
Plan a consultation